Luteal support with vaginal micronized progesterone gel in assisted reproduction

Reproductive BioMedicine Online

Volumn 6, Issue 3, 2003, Pages 287-295

  Penzias, Alan S ^a   Alper, Michael M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Assisted reproduction; Crinone 8 ; IVF; Luteal support; Progesterone; Vaginal administration

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHORIONIC GONADOTROPIN; DRUG VEHICLE; GONADORELIN DERIVATIVE; HYDROXYPROGESTERONE; ORAL CONTRACEPTIVE AGENT; POLYCARBOPHIL; PROGESTERONE; SUPPOSITORY BASE;

CLINICAL TRIAL; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG TOLERABILITY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; LUTEAL PHASE; NERVE INJURY; NIDATION; OVARY DISEASE; PATIENT SATISFACTION; PREGNANCY RATE; REVIEW; SCIATIC NERVE; SEDATION; SENSORIMOTOR NEUROPATHY; SPONTANEOUS ABORTION; UTERINE BLEEDING PATTERN;

EID: 0037561079     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61847-0     Document Type: Article

References (57)

1. Abate A, Brigandi A, Abate FG et al. 1999 Luteal phase support with 17alpha-hydroxyprogesterone versus unsupported cycles in in vitro fertilization: a comparative randomized study. Gynecologic and Obstetric Investigation 48, 78-80.
2. Abramowicz JS, Archer DF 1990 Uterine endometrial peristalsis - a transvaginal ultrasound study. Fertility and Sterility 54, 451-454.
3. Alper MM, Penzias AS 2000 Crinone® offers excellent implantation rates in patients undergoing in vitro fertilization (IVF). Presented at the 16th Annual Meeting of the European Society of Human Reproduction and Embryology, Bologna, Italy, June 2000, P-059 (abstr.).
4. Arafat ES, Hargrove JT, Maxson WS et al. 1988 Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites. American Journal of Obstetrics and Gynecology 159, 1203-1209.
5. Araujo E Jr, Bernardini L, Frederick JL et al. 1994 Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction. Journal of Assisted Reproduction and Genetics 11, 74-78.
6. Barnhart K, Sammel M 2002 The truth is out there: a guide to the pitfalls of interpreting evidence-based medicine in studies of human reproduction. Fertility and Sterility 77, 223-228.
7. Bates GW Jr, Ginsburg ES 2002 Early pregnancy loss in in vitro fertilization (IVF) is a positive predictor of subsequent IVF success. Fertility and Sterility 77, 337-341.
8. Belaisch-Allart J, de Mouzon J, Lapousterle C et al. 1990 The effect of HCG supplementation after combined GnRH agonist/HMG treatment in an IVF programme. Human Reproduction 5, 163-166.
9. Bourgain C, Devroey P, Van Waesberghe L et al. 1990 Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Human Reproduction 5, 537-543.
10. Bulletti C, de Ziegler D, Flamigni C et al. 1997 Targeted drug delivery in gynaecology: the first uterine pass effect. Human Reproduction 12, 1073-1079.
11. Buvat J, Marcolin G, Guittard C et al. 1990 Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone. Fertility and Sterility 53, 490-494.
12. Centers for Disease Control and Prevention, US Department of Health and Human Services 1998 1996 Assisted Reproductive Technology Success Rates. Palladian Partners, Atlanta, p. 54.
13. Chantilis SJ, Zeitoun KM, Patel SI et al. 1999 Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. Fertility and Sterility 72, 823-829.
14. Cicinelli E, de Ziegler D 1999 Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus. Human Reproduction Update 5, 365-372.
15. Cicinelli E, Cignarelli M, Sabatelli S et al. 1998 Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women. Fertility and Sterility 69, 471-473.
16. Cicinelli E, de Ziegler D, Bulletti C et al. 2000 Direct transport of progesterone from vagina to uterus. Obstetrics and Gynecology 95, 403-406.
17. 99mTc-pertechnetate in postmenopausal women. Fertility and Sterility 76, 1108-1112.
18. Claman P, Domingo M, Leader A 1992 Luteal phase support in invitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone. Human Reproduction 7, 487-489.
19. Coutifaris C, Patrizio P, Schafer D et al. 2000 Is the use of Crinone for support of the luteal phase detrimental to pregnancy outcome after transfer of non-cryopreserved embryos in good prognosis patients? A preliminary report. Fertility and Sterility 74(3S), S205, P-350 (abstr.).
20. de Ziegler D, Fanchin R, Massonneau M et al. 1994 Hormonal control of endometrial receptivity. The egg donation model and controlled ovarian hyperstimulation. Annals of the New York Academy of Sciences 734, 209-220.
21. Devroey P, Palermo G, Bourgain C et al. 1989 Progesterone administration in patients with absent ovaries. International Journal of Fertility and Women's Medicine 34, 188-193.
22. Einer-Jensen N, Kotwica J, Krzymowski T et al. 1993 Rapid absorption and local redistribution of progesterone after vaginal application in gilts. Acta Veterinaria Scandinavica 34, 1-7.
23. Fanchin R, de Ziegler D, Bergeron C et al. 1997 Transvaginal administration of progesterone. Obstetrics and Gynecology 90, 396-401.
24. Fanchin R, Righini C, Olivennes F et al. 1998 Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Human Reproduction 13, 1968-1974.
25. Friedler S, Raziel A, Schachter M et al. 1999 Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration. Human Reproduction 14, 1944-1948.
26. Germond M, Capelli P, Bruno G et al. 2002 Comparison of the efficacy and safety of two formulations of micronized progesterone used as luteal phase support after in vitro fertilization. Fertility and Sterility 77, 313-317.
27. Gibbons WE, Toner JP, Hamacher P et al. 1998 Experience with a novel vaginal progesterone preparation in a donor oocyte program. Fertility and Sterility 69, 96-101.
28. Herman A, Ron-El R, Golan A et al. 1990 Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins. Fertility and Sterility 53, 92-96.
29. Jobanputra K, Toner JP, Denoncourt R et al. 1999 Crinone 8% (90 mg) given once daily for progesterone replacement therapy in donor egg cycles. Fertility and Sterility 72, 980-984.
30. Jones HW Jr, Jones GS, Hodgen GD et al. (eds) 1986 IVF-Norfolk. Williams and Wikins, Baltimore, p. 232.
31. Kline DG, Kim D, Midha R et al. 1998 Management and results of sciatic nerve injuries: a 24-year experience. Journal of Neurosurgery 89, 13-23.
32. Kolb BA, Paulson RJ 1997 The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation. American Journal of Obstetrics and Gynecology 176, 1262-1269.
33. Levine H 2000 Luteal support in IVF using the novel vaginal progesterone gel Crinone 8%: results of an open-label trial in 1184 women from 16 US centers. Fertility and Sterility 74, 836-837.
34. Levine H, Watson N 2000 Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women. Fertility and Sterility 73, 516-521.
35. Licciardi FL, Kwiatkowski A, Noyes NL et al. 1999 Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study. Fertility and Sterility 71, 614-618.
36. Ludwig M, Diedrich K 2001 Evaluation of an optimal luteal phase support protocol in IVF. Acta Obstetricia et Gynecologica Scandinavica 80, 452-466.
37. Miles RA, Paulson RJ, Lobo RA et al. 1994 Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertility and Sterility 62, 485-490.
38. Mochtar MH, Hogerzeil HV, Mol BW 1996 Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial. Human Reproduction 11, 1602-1605.
39. Nahoul K, Dehennin L, Jondet M et al. 1993 Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone. Maturitas 16, 185-202.
40. Penzias AS 1995 Luteal phase support. Seminars in Reproductive Endocrinology 13, 32-38.
41. Penzias AS 2002 Luteal phase support. Fertility and Sterility 77, 318-323.
42. Pouly JL, Bassil S, Frydman R et al. 1996 Luteal support after invitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone. Human Reproduction 11, 2085-2089.
43. Probst AM, Hill JA, Ginsburg ES et al. 2001 A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles. Fertility and Sterility 76, 1144-1149.
44. Romàn E, Aytoz A, Smitz JE et al. 2000 Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone. Human Reproduction 7, 1435-1439.
45. Saucedo LLE, Galache VP, Hernández AS et al. 2000 Randomized trial of three different forms of progesterone supplementation in ART: preliminary results. Fertility and Sterility 74 (suppl. 1), S 150, P-175 (abstr.).
46. Schoolcraft WB, Hesla JS, Gee MJ 2000 Experience with progesterone gel for luteal support in a highly successful IVF programme. Human Reproduction 15, 1284-1288.
47. Schwartz P, Ludwig M, Babahan B et al. 2000 Luteal phase support using either progesterone gel (Crinone 8%) or progesterone suppositories (Utrogest): results of a prospective, randomized study. Presented at the 16th Annual Meeting of the European Society of Human Reproduction and Embryology, Bologna, Italy, June 2000, O-111 (abstr.).
48. Smith EM, Anthony FW, Gadd SC et al. 1989 Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme. British Medical Journal 298, 1483-1486.
49. Smitz J, Bourgain C, Van Waesberghe L et al. 1993 A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation. Human Reproduction 8, 40-45.
50. Smitz J, Devroey P, Faguer B et al. 1992a A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Human Reproduction 7, 168-175.
51. Smitz J, Erard P, Camus M et al. 1992b Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. Human Reproduction 7, 1225-1229.
52. Soliman S, Daya S, Collins J et al. 1994 The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertility and Sterility 61, 1068-1076.
53. Tavaniotou A, Smitz J, Bourgain C et al. 2000 Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Human Reproduction Update 6, 139-148.
54. Toner JP, Hassiakos DK, Muasher SJ et al. 1991 Endometrial receptivities after leuprolide suppression and gonadotropin stimulation: histology, steroid receptor concentrations, and implantation rates. Annals of the New York Academy of Sciences 622, 220-229.
55. Toner JP, Singer GA, Jones HW Jr 1993 Uterine receptivity after ovarian stimulation for assisted reproduction. In: Giarardi L, Compara A, Trounson AO (eds) Implantation in Mammals. Raven Press, New York, pp. 231-238.
56. Van Steirteghem AC, Smitz J, Camus M et al. 1988 The luteal phase after in-vitro fertilization and related procedures. Human Reproduction 3, 161-164.
57. Williams SC, Donohoe J, Muasher SJ 2000 Vaginal progesterone therapy during programmed cycles for frozen embryo transfer: an analysis of serum progesterone levels and pregnancy rates. Fertility and Sterility 74(3S), S209, P-363 (abstr.).